Physician profile
Nicholas D Coppa
NPI 1205017605
$4,578.19
in general payments reported to CMS, 2019-2025
12 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $28.77 · 2021: $95.92 · 2022: $115 · 2023: $31.64 · 2024: $3,774 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,048 · Food and Beverage: $1,187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,048.32 |
| Food and Beverage | $1,186.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $3,497.04 | 2024 | Other - Miscellaneous, Biologics |
| Medtronic, INC. | $310.76 | 2021-2025 | Stealthstation S8 Platform, Kyphon Express II Kyphopak Tray |
| Depuy Synthes Sales INC. | $262.25 | 2021-2025 | Velys, Skyline |
| Cerapedics INC. | $176.32 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Orthofix Medical, INC. | $140.25 | 2019-2025 | Cervical-Stim, Spinal-Stim |
| Abbvie INC. | $53.47 | 2024 | |
| Medical Device Business Services, INC. | $31.64 | 2023 | Conduit |
| Boston Scientific Corporation | $25.74 | 2025 | Intracept |
| Medtronic USA, INC. | $23.84 | 2019-2020 | |
| Amgen INC. | $19.57 | 2019 | |
| Relievant Medsystems, INC. | $19.57 | 2022 | |
| Integra Lifesciences Corporation | $17.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Coppa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.